These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 19929840)

  • 1. An update on the synthesis and antibacterial effects of carbapenems.
    Galal AM; Gul W; Noreddin AM; Slade D
    Recent Pat Antiinfect Drug Discov; 2010 Jan; 5(1):23-43. PubMed ID: 19929840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Doripenem: a review of its use in the treatment of bacterial infections.
    Keam SJ
    Drugs; 2008; 68(14):2021-57. PubMed ID: 18778123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of the carbapenems in clinical use and clinical trials.
    Lo TS; Welch JM; Alonto AM; Vicaldo-Alonto EA
    Recent Pat Antiinfect Drug Discov; 2008 Jun; 3(2):123-31. PubMed ID: 18673125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Available carbapenems: Properties and differences].
    Martínez MJ; García MI; Sánchez EG; Sánchez JE
    Enferm Infecc Microbiol Clin; 2010 Sep; 28 Suppl 2():53-64. PubMed ID: 21130931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative review of the carbapenems.
    Zhanel GG; Wiebe R; Dilay L; Thomson K; Rubinstein E; Hoban DJ; Noreddin AM; Karlowsky JA
    Drugs; 2007; 67(7):1027-52. PubMed ID: 17488146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Doripenem: position in clinical practice.
    Dedhia HV; McKnight R
    Expert Rev Anti Infect Ther; 2009 Jun; 7(5):507-14. PubMed ID: 19485791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Doripenem monohydrate, a broad-spectrum carbapenem antibiotic.
    Matthews SJ; Lancaster JW
    Clin Ther; 2009 Jan; 31(1):42-63. PubMed ID: 19243706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nosocomial infections: new therapeutic alternatives.
    Buron JA; Rossolini GM; Cerrato SG; Rello J; Zaragoza R; Rodriguez JA; Garau J
    Expert Rev Anti Infect Ther; 2010 Nov; 8(11):1217-9. PubMed ID: 21073285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbapenems: a potent class of antibiotics.
    Nicolau DP
    Expert Opin Pharmacother; 2008 Jan; 9(1):23-37. PubMed ID: 18076336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New developments in carbapenems.
    Kattan JN; Villegas MV; Quinn JP
    Clin Microbiol Infect; 2008 Dec; 14(12):1102-11. PubMed ID: 19076841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Doripenem: an expected arrival in the treatment of infections caused by multidrug-resistant Gram-negative pathogens.
    Poulakou G; Giamarellou H
    Expert Opin Investig Drugs; 2008 May; 17(5):749-71. PubMed ID: 18447600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbapenem-hydrolyzing gram-negative bacteria: current options for treatment and review of drugs in development.
    Abandeh FI; Drew ME; Sopirala MM
    Recent Pat Antiinfect Drug Discov; 2012 Apr; 7(1):19-27. PubMed ID: 22211694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doripenem (Doribax)--a new parenteral carbapenem.
    Med Lett Drugs Ther; 2008 Jan; 50(1278):5-7. PubMed ID: 18219262
    [No Abstract]   [Full Text] [Related]  

  • 14. Role and impact of carbapenem in nosocomial infections.
    Goulenok TM; Majed K; Monchi M
    Recent Pat Antiinfect Drug Discov; 2011 Jan; 6(1):45-53. PubMed ID: 21192777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbapenems vs. alternative β-lactams for the treatment of nosocomial pneumonia: A systematic review and meta-analysis.
    O'Donnell JN; Rhodes NJ; Lopez J; Jett R; Scheetz MH
    Int J Antimicrob Agents; 2018 Oct; 52(4):451-458. PubMed ID: 29665442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The role of carbapenems in the treatment of nosocomial infection].
    Martínez Lacasa J; Garau J
    Enferm Infecc Microbiol Clin; 1997 Sep; 15 Suppl 1():78-85. PubMed ID: 9410075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Doripenem: a new carbapenem antibiotic.
    Chahine EB; Ferrill MJ; Poulakos MN
    Am J Health Syst Pharm; 2010 Dec; 67(23):2015-24. PubMed ID: 21098373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of carbapenems in the treatment of severe nosocomial respiratory tract infections.
    Joseph J; Rodvold KA
    Expert Opin Pharmacother; 2008 Mar; 9(4):561-75. PubMed ID: 18312158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli.
    Zhanel GG; Golden AR; Zelenitsky S; Wiebe K; Lawrence CK; Adam HJ; Idowu T; Domalaon R; Schweizer F; Zhanel MA; Lagacé-Wiens PRS; Walkty AJ; Noreddin A; Lynch Iii JP; Karlowsky JA
    Drugs; 2019 Feb; 79(3):271-289. PubMed ID: 30712199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and antibacterial activity of some novel 6-methyl- and 6-propenyl-substituted carbapenems.
    Mastalerz H; Menard M; Ruediger E; Fung-Tomc J
    J Med Chem; 1992 Mar; 35(5):953-8. PubMed ID: 1548685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.